Skip to main content
WGS
NASDAQ Industrial Applications And Services

Director & 10% Owner Casdin Partners Buys $21.4M in GeneDx Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$44.396
Mkt Cap
$1.328B
52W Low
$32.21
52W High
$170.87
52W Position info
38% above low
Off High info
74% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

WGS sits 38% above its 52-week low of $32.21.

Summary

Casdin Partners, a Director and 10% owner of GeneDx Holdings Corp., purchased $21.46 million worth of Class A Common Stock in open market transactions.


Key Events · Ownership and Investor Activity · WGS

  • Significant Insider Purchase

    Casdin Partners, a Director and 10% owner, acquired $21.46 million worth of Class A Common Stock through open market purchases between May 18 and May 20, 2026.

  • Continued Accumulation

    This transaction follows previous large acquisitions by Casdin Partners and other insiders, contributing to a net accumulation of over $66 million in the last 90 days, indicating a sustained buying trend.

  • Conviction Amidst Challenges

    The substantial investment by a key insider suggests strong confidence in the company's long-term prospects, especially as it occurs after the company reported a significant Q1 net loss and reduced its full-year revenue forecast.


Analysis · WGS · Industrial Applications And Services

Casdin Partners, a Director and 10% owner, made a substantial open market purchase of GeneDx stock, investing over $21.4 million. This significant accumulation, representing over 1.6% of the company's market capitalization, signals strong insider conviction. The purchase is particularly notable as it follows recent negative financial news, including a significant Q1 net loss and a reduced full-year revenue forecast. This continued buying by a key insider provides a counter-signal to the market's recent concerns.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WGS was trading at $44.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $32.21 to $170.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WGS - Latest Insights

WGS
Aug 03, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.01
Real-time Price: $89.50 info
Change: +$12.49 (+16%) info
Market Cap: $2.676B info
WGS
Aug 03, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $62.47
Real-time Price: $89.50 info
Change: +$27.03 (+43%) info
Market Cap: $2.676B info
WGS
Aug 03, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $60.19
Real-time Price: $89.50 info
Change: +$29.31 (+49%) info
Market Cap: $2.676B info
WGS
Jul 16, 2026, 10:09 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $65.44
Real-time Price: $89.50 info
Change: +$24.06 (+37%) info
Market Cap: $2.676B info
WGS
Jul 07, 2026, 8:46 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $65.01
Real-time Price: $89.50 info
Change: +$24.49 (+38%) info
Market Cap: $2.676B info